TriContinent
Lee Carter is a seasoned professional with significant experience in business development and investment within the lab automation sector. Currently serving as a Private Investor at LabAutomation since July 2016, Lee focuses on funding small startup lab automation companies and developing real estate projects, including a 10-unit development in downtown Philadelphia with an attached restaurant. Prior to this role, Lee acted as the Director of Business Development and CEO at TriContinent from January 2010 until its acquisition by Gardner Denver (KKR) in May 2015, thereafter continuing as a business development manager until July 2016. Lee's earlier experience includes serving as a Sales and Marketing Manager and Principal Consultant in the lab automation field from January 2007 to January 2011. Lee holds a degree from the University of Delaware.
This person is not in any teams
This person is not in any offices
TriContinent
TriContinent is a leading manufacturer of liquid handling solutions for Original Equipment Manufacturers (OEMs) in the medical, pharmaceutical, biotechnology, and laboratory industry. With its experienced Engineering, Technical, and Operations staff and capabilities, TriContinent designs and manufactures standard and customized syringe pumps, pipetting pumps, rotary valves, syringes, and liquid handling (XYZ) robots that meet the precise needs of its customers. Backed by over 45 years of engineering excellence and innovation and a global manufacturing network, TriContinent stands out as the reliable choice for OEMs worldwide. TriContinent Scientific is an Ingersoll Rand Business. Ingersoll Rand is a global market leader with a broad range of innovative and mission-critical air, fluid, energy, and medical technologies, providing services and solutions to increase industrial productivity and efficiency.